Glucotrack announces the appointment of erin carter to board of directors

Rutherford, nj, aug. 31, 2023 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has appointed erin carter to its board of directors and as chair of its audit committee, effective immediately.
GCTK Ratings Summary
GCTK Quant Ranking